Early diagnosis of brain metastases using a biofluids-metabolomics approach in mice
<p>Over 20% of cancer patients will develop brain metastases. Prognosis is currently extremely poor, largely owing to late-stage diagnosis. We hypothesized that biofluid metabolomics could detect tumours at the micrometastatic stage, prior to the current clinical gold-standard of blood-brain b...
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Journal article |
| Pubblicazione: |
Ivyspring International Publisher
2016
|